Why choose Geisinger for TAVR?
TAVR (transcatheter aortic valve replacement) is a minimally invasive procedure used to treat aortic stenosis — a condition where the aortic valve narrows and restricts blood flow. Unlike traditional open heart surgery, TAVR is done through a small incision, typically in the groin.
Using a thin, flexible catheter, your doctor guides a replacement valve into your heart. Then they position it inside the damaged valve. Once in place, the new valve expands and starts working immediately, restoring healthy blood flow. The procedure usually takes less than 1 hour and involves less pain, a shorter hospital stay and a faster recovery than open surgery.
We were the first heart program in central and northeastern Pennsylvania to offer TAVR, and we perform more TAVR procedures than any other program in the region.
Interested in TAVR? Ask your primary care provider or cardiologist for a referral.
Conditions we treat
Related specialties
FAQs
What are the benefits of TAVR?
TAVR offers several advantages over traditional open heart surgery:
- Minimally invasive alternative to open heart surgery
- Suitable for patients at low, medium or high surgical risk
- Quicker recovery and faster return to daily activities
If I’m interested in TAVR, what should I do next?
First, speak to your primary care provider or cardiologist. They can refer you to Geisinger’s Valve Clinic, where our specialists will evaluate your condition and discuss treatment options, including minimally invasive procedures like TAVR.
Your health journey starts with a conversation. Trust your instincts. Talk to your doctor.
How has TAVR helped other patients?
Transcatheter aortic valve replacement (TAVR) at Geisinger
Come to us because you trust our care. Stay because you’ll have access to all this:
- Regional leader: We were the first heart program in central and northeastern Pennsylvania to offer TAVR — and we've performed more TAVR procedures than any other program in the region.
- Excellent outcomes: TAVR patients here have a history of excellent outcomes and long-term success.
- Expanding options through innovation: Thanks to participation in national clinical trials, TAVR is now available to patients at low surgical risk — a group that previously didn't qualify.
- Powered by Edwards Lifesciences technology: We use the Edwards SAPIEN 3 Ultra RESILIA™ transcatheter heart valve, known for its durability, safety and long-term performance.